Trial Profile
A pilot study of Susceptibility testing based Fourth-line Helicobacter pylori eradication therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jan 2022
Price :
$35
*
At a glance
- Drugs Amoxicillin (Primary) ; Clarithromycin (Primary) ; Metronidazole (Primary) ; Vonoprazan (Primary)
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 24 Jan 2022 Status changed from recruiting to completed.
- 23 Jan 2017 New trial record